The government’s decision-making proposal on the subject was passed in July 2021. Following this decision, the Accountant General of the Ministry of Finance issued a call on 18 November, 2021 for foreign and Israeli companies to examine their interest in establishing a vaccine manufacturing plant in Israel (see the approach to market attached to this mail). The call will close on March 17, 2022. It should be noted that the call is very general in terms of the value proposition that the government is willing to offer companies interested in this project.


We are calling relevant pharmaceutical companies and other parties who is interested in establishing a vaccine plant in Israel to participate. Note that knowledge in vaccine production is very specific and therefore it is likely that only pharmaceutical companies that already produce vaccines will be relevant for this call.


For more information, please find the attachment: en_files_kol-kore-approach-to-market-update.